Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Live: Budget 2023: Will India Spend More?
Budget 2023
Budget 2023
you are here: HomeNewsBusiness

Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in Aleor, which has presence across cream, gel, ointment, shampoo, lotion, solutions, sprays, foams, microsponge and nanoparticulate platform-based product segments.

March 29, 2022 / 02:14 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Alembic Pharmaceuticals on Tuesday said it has fully acquired Aleor Dermaceuticals from its joint venture partner Orbicular, to strengthen its skin-related manufacturing and marketing footprint.

The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in Aleor, which has presence across cream, gel, ointment, shampoo, lotion, solutions, sprays, foams, microsponge and nanoparticulate platform-based product segments.

The company, however, did not share financial details.

"We think it (derma) is a promising area and we wanted to take 100 per cent of the company. So we bought out the remaining 40 per cent so that we have more control and can explore opportunities in the future,” Alembic Pharmaceuticals Managing Director Pranav Amin told PTI.